[Federal Register Volume 82, Number 57 (Monday, March 27, 2017)]
[Notices]
[Pages 15221-15222]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05932]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 Day-17-16BFQ]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and
[[Page 15222]]
instruments, call (404) 639-7570 or send an email to [email protected].
Written comments and/or suggestions regarding the items contained in
this notice should be directed to the Attention: CDC Desk Officer,
Office of Management and Budget, Washington, DC 20503 or by fax to
(202) 395-5806. Written comments should be received within 30 days of
this notice.
Proposed Project
Survey of Sexually Transmitted Disease (STD) Provider Practices in
the United States--NEW--National Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Each year, 19.7 million sexually transmitted diseases (STDs) occur
in the U.S., half of which strike youth 15-24 years of age. The public
health burden of STDs is compounded by their economic impact. In 2010,
an estimated $15.6 billion in direct medical costs were attributed to
STDs. Undiagnosed and untreated STDs can lead to serious long-term
health consequences, especially for adolescent girls and young adult
women. For example, every year, about 24,000 young women become
infertile as a result of undiagnosed and untreated STDs.
There is no national survey that collects detailed information on
the STD practices of physicians. The STD Provider Survey will collect
much needed data from U.S. health care providers in five specialties:
Primary care (including internal medicine), general or family practice,
obstetrics/gynecology, emergency medicine, and pediatrics. Knowledge of
provider practices relative to guidelines and state-level laws and
policies will provide information useful to stakeholders at all levels
regarding the delivery of STD preventive services and treatment by
health care providers in the U.S. As providers are one of the few
professionals who have face-to-face contact with persons infected with
STDs, they are also a potential intervention point for attempts to
reduce re-infection and halt the further transmission of STDs.
The purpose of this survey is to conduct a nationally
representative survey of physicians in five specialities: Primary care
(including internal medicine), general or family practice, obstetrics/
gynecology, emergency medicine, and pediatrics. Our sample size of
physicians will allow for national estimates and comparisons among
these five specialties. Additionally, the survey will provide national
estimates for comparisons between providers in the public and private
sectors. Information collected will also be used to determine STD
prevention activities needed by type of providers (by specialty or
public/private) based on findings related to screening and treatment
practices for STDs including EPT.
The survey contains sections on the physician's specialty areas,
primary practice setting, primacy practice policies, patient
demographics, STD testing and diagnosis, STD care and treatment, and
respondent demographics.
In an effort to better understand policies and practices for STD
care delivery among medical providers, the surveys will be sent to a
random sample of 5,000 U.S. physicians across several specialties using
the American Medical Association Master file. Using a multimode design
(mail and web), multiple reminders will be sent to non-responders in
order to reach the target of 3,500 completed surveys. The total burden
hours are 1,342. There is no cost to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Physicians responding via Mail........ STD Provider Survey..... 2,625 1 20/60
Physicians responding via Web......... STD Provider Survey..... 875 1 32/60
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-05932 Filed 3-24-17; 8:45 am]
BILLING CODE 4163-18-P